Oscar Health Stock Is Trending After Jumping 12% On Monday: What's Going On? - Oscar Health (NYSE:OSCR)
Oscar Health (NYSE:OSCR) shares rose 11.75% to $27.39 on Monday and added 0.77% to $27.60 after hours, after management cited favorable operating trends at the Goldman Sachs 47th Annual Global Healthcare Conference. CFO Scott Blackley said 2026 is off to a “very strong start,” with utilization modestly favorable through May and a final 2025 Wakely report $130 million better than first-quarter assumptions. Oscar reiterated 2026 guidance: revenue $18.7B–$19B and operating earnings $250M–$450M.
How this was made
The 30-second read
Why it matters
Favorable utilization through May and a Wakely report coming in $130M better than first-quarter assumptions were used to support a “very strong start” and reaffirm 2026 guidance.
Market read
Traders received concrete operating-trend datapoints and a reaffirmation of 2026 revenue and operating earnings ranges, coinciding with a large single-session rally.
What to watch
The article notes management is waiting for additional market data before changing guidance—timing of that data could drive volatility and mean-reversion risk.
Background
Oscar Health management discussed operating trends at the Goldman Sachs 47th Annual Global Healthcare Conference, including utilization and actuarial report impacts.
Ticker impact
Oscar Health shares jumped after CFO Scott Blackley cited favorable utilization through May and a final 2025 Wakely report $130M better than assumptions.
Near-term momentum likely supported, but upside may hinge on whether subsequent market data leads to any guidance change.
The article ties the same-day +11.75% move to specific, attributable operating-trend datapoints and reiteration of full-year 2026 guidance.
Market effects
Positive read-through for managed-care/health-insurance tech names if utilization and actuarial accruals remain favorable.
Primarily US-listed single-name momentum; limited direct regional spillover implied.
Low—no cross-border deal/regulatory developments mentioned.
Counterpoint
The catalyst is management commentary at a conference; without a new guidance revision, the move could fade if later data doesn’t confirm tailwinds.
Key entities
- companyOscar Health Inc
US health insurer/healthcare technology company whose stock surged on conference operating-trend commentary.
- executiveScott Blackley
CFO who cited favorable utilization trends and a $130M better-than-assumed final 2025 Wakely report.
- executiveMark Bertolini
CEO who previously said steps were taken to return to profitability in 2026.
